Cargando…
Molecular Biomarkers in Fragile X Syndrome
Fragile X syndrome (FXS) is the most common inherited form of intellectual disability (ID) and a known monogenic cause of autism spectrum disorder (ASD). It is a trinucleotide repeat disorder, in which more than 200 CGG repeats in the 5’ untranslated region (UTR) of the fragile X mental retardation...
Autores principales: | Zafarullah, Marwa, Tassone, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562871/ https://www.ncbi.nlm.nih.gov/pubmed/31035599 http://dx.doi.org/10.3390/brainsci9050096 |
Ejemplares similares
-
Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS)
por: Zafarullah, Marwa, et al.
Publicado: (2020) -
De Novo Large Deletion Leading to Fragile X Syndrome
por: Jiraanont, Poonnada, et al.
Publicado: (2022) -
Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X‐Associated Tremor/Ataxia Syndrome (FXTAS)
por: Zafarullah, Marwa, et al.
Publicado: (2020) -
FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Zafarullah, Marwa, et al.
Publicado: (2020) -
Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2021)